Search results for "OBESITY"

showing 10 items of 1833 documents

Factors reducing omalizumab response in severe asthma

2018

Background: Despite adding Omalizumab to conventional therapy, several severe asthmatics still show poor disease control. We investigated the factors that may affect a reduced Omalizumab response in a large population of severe asthmatics. Methods: 340 patients were retrospectively evaluated. FEV1%, FVC%, Asthma Control Test (ACT), fractional exhaled nitric oxide (FENO), possible step-downs/step-ups of concomitant therapies, exacerbations, disease control levels, ICS doses and SABA use, observed at the end of treatment, were considered as a response to Omalizumab. Results: Age was an independent risk factor for a reduced response concerning FEV1%, FVC%, ACT and for a lower asthma control. O…

MaleSevere asthmaDrug ResistanceComorbidityOmalizumabOmalizumabAdrenal Cortex HormoneComorbidities0302 clinical medicineRetrospective StudieAdrenal Cortex HormonesRisk FactorsForced Expiratory VolumeAge FactorNasal polypsAnti-Asthmatic Agents030212 general & internal medicineMultivariate AnalysiSmokingAge FactorsReal-lifeMiddle AgedTreatment OutcomeItalyFemaleComorbiditieHumanmedicine.drugAdultage; comorbidities; obesity; omalizumab; real-life; severe asthma; therapeutic response; internal medicinemedicine.medical_specialtyLogistic ModelTherapeutic responseSettore MED/10 - Malattie Dell'Apparato RespiratorioNitric Oxide03 medical and health sciencesFEV1/FVC ratioNasal PolypsAgeInternal medicineInternal MedicinemedicineAnti-Asthmatic AgentHumansObesityRisk factorRetrospective StudiesAsthmabusiness.industryRisk Factormedicine.diseaseComorbidityAsthmarespiratory tract diseasesLogistic Models030228 respiratory systemConcomitantMultivariate AnalysisExhaled nitric oxideNasal PolypAge; Comorbidities; Obesity; Omalizumab; Real-life; Severe asthma; Therapeutic responsebusinessEuropean Journal of Internal Medicine
researchProduct

Consistency of effect of ezetimibe/simvastatin compared with intensified lipid-lowering treatment strategies in obese and non-obese diabetic subjects

2013

Purpose: This post hoc analysis assessed switching to ezetimibe/simvastatin 10/20 mg vs doubling the baseline statin dose to simvastatin 40 mg or atorvastatin 20 mg or switching to rosuvastatin 10 mg in subgroups of obese (BMI ≥30 kg/m 2 ) and non-obese (BMI <30 kg/m 2 ) diabetic subjects. Methods: This was a randomized, double-blind, 12-week study of adults 18–79 years with cardiovascular disease with low-density lipoprotein cholesterol (LDL-C) ≥70 and ≤160 mg/dl. Percent change in LDL-C and other lipids was estimated. Results: In obese subjects (n = 466), percent changes in LDL-C and most other lipids were greater with ezetimibe/ simvastatin vs doubling the baseline statin dose or switchi…

MaleSimvastatinApolipoprotein BEndocrinology Diabetes and MetabolismAtorvastatinClinical Biochemistrychemistry.chemical_compoundEndocrinologyAtorvastatinRosuvastatin CalciumSulfonamidesNutrition and DieteticsbiologyAnticholesteremic AgentsDiabetesMiddle AgedRosuvastatin CalciumTreatment OutcomeFemalelipids (amino acids peptides and proteins)Cardiology and Cardiovascular Medicinemedicine.drugAdultmedicine.medical_specialtyStatinAdolescentmedicine.drug_classUrologyRosuvastatinYoung AdultEzetimibeDiabetes mellitusInternal medicineInternal MedicinemedicineHumansPyrrolesRosuvastatinObesitycardiovascular diseasesAgedApolipoproteins BBiochemistry medicalCholesterolbusiness.industryResearchBiochemistry (medical)Statinnutritional and metabolic diseasesCholesterol LDLEzetimibemedicine.diseasePeptide FragmentsFluorobenzenesDiabetes Mellitus Type 1PyrimidinesEndocrinologyDiabetes Mellitus Type 2chemistryHeptanoic AcidsSimvastatinbiology.proteinAzetidinesEzetimibe/simvastatinbusinessLipids in Health and Disease
researchProduct

A Time-Lagged, Actor–Partner Interdependence Analysis of Alliance to the Group as a Whole and Group Member Outcome in Overweight and Obesity Treatmen…

2014

A time-lagged design was used to examine how the perceptions of alliance to the group as a whole by the other group members at an earlier point in the group were related to an individual group member’s perceptions of alliance to the group as a whole at a later point in the group. We also examined how treatment outcome moderated this relationship. Seventy-three patients diagnosed as overweight or obese participating in 10 short-term therapy groups provided data for analyses. Group members completed measures of cohesion to the group and alliance to the group as a whole at the third, sixth, and last session of 12-session groups as well as pre- and posttest ratings on Obesity-Related Well-Being…

MaleSocial PsychologyTreatment outcomegroup therapy alliance to the group obesity actor-partner interdependence modelOverweightOutcome (game theory)Treatment and control groupsGroup (periodic table)Surveys and QuestionnairesmedicineHumansInterpersonal RelationsObesityGeneral MedicineMiddle AgedOverweightmedicine.diseaseObesityGroup ProcessesPsychiatry and Mental healthClinical PsychologyAllianceTreatment OutcomeItalyPsychotherapy GroupPositive relationshipFemalemedicine.symptomPsychologyClinical psychologyFollow-Up Studies
researchProduct

Liver and pancreatic fat content and metabolism in healthy monozygotic twins with discordant physical activity

2011

Background &amp; Aims: Ectopic fat in muscle and liver is linked to obesity and type 2 diabetes. Recently, pancreatic lipid accumulation has also been associated with beta-cell dysfunction and reduced insulin production, leading to the development of type 2 diabetes. Physical exercise training has been shown to attenuate beta-cell dysfunction in patients, but little is known about its effects on pancreatic and hepatic fat accumulation. In this study, we validated in-vivo proton magnetic resonance spectroscopy ((1)H MRS) in pancreatic fat measurement with biochemical measurements in a pig model. Thereafter, the effects of increased physical activity on the amounts of pancreatic and liver fat…

MaleSwinemedicine.medical_treatmentSus scrofaAdipose tissueMonozygotic twinACID UPTAKEType 2 diabetesFatty Acids NonesterifiedFat Measurement0302 clinical medicineFatty AcidsHEPATIC INSULIN-RESISTANCEMagnetic Resonance Imagingmedicine.anatomical_structureADIPOSE-TISSUEAdipose TissueLiverModels AnimalSwine Miniature030211 gastroenterology & hepatologyPancreasMonozygotic twinsAdultmedicine.medical_specialty030209 endocrinology & metabolismDEPENDENT DIABETES-MELLITUSMotor ActivityBiologyta3111HISPANIC ADOLESCENTSYoung Adult03 medical and health sciencesInsulin resistanceBETA-CELL FUNCTIONInternal medicineMagnetic resonance spectroscopymedicineMAGNETIC-RESONANCE SPECTROSCOPYAnimalsHumansADIPONECTIN CONCENTRATIONSPancreasPLASMA ADIPONECTINHepatologyPhysical activityInsulinTRIGLYCERIDE CONTENTTwins MonozygoticLipid Metabolismmedicine.diseaseObesityEndocrinologyInsulin ResistanceJournal of Hepatology
researchProduct

Sympathetic neural activity, metabolic parameters and cardiorespiratory fitness in obese youths.

2017

OBJECTIVE: The main objective of this cross-sectional study is to assess the cardiac autonomic neural activity in the presence of abnormally increased body weight in youths and its relationship to metabolic risk factors and cardiorespiratory fitness (CRF). METHODS: Sixty-four overweight and obese patients, aged 9-17 years, of both sexes, stratified according to the international BMI cut-off, were enrolled. Continuous ECG was recorded during 15 min in resting conditions, and the heart rate variability (HRV) was measured in the time domain, frequency domain and for nonlinear dynamics. In addition, cardiometabolic risk factors and CRF in effort conditions were assessed. RESULTS: Among the over…

MaleSympathetic nervous systemYouthPhysiologyCross-sectional study030204 cardiovascular system & hematologyOverweightAdolescentsElectrocardiography0302 clinical medicineHeart RateRisk FactorsInsulinAutonomic Pathways030212 general & internal medicineChildHeartmedicine.anatomical_structureCardiorespiratory FitnessCardiorespiratory fitneCardiologyObesitatFemalemedicine.symptomCardiology and Cardiovascular Medicinemedicine.medical_specialtyAdolescent03 medical and health sciencesInsulin resistanceOxygen ConsumptionInternal medicineHeart rateInternal MedicinemedicineHumansObesitySistema cardiovascularMetabolic parameterbusiness.industryAutonomic PathwaysCardiorespiratory fitnessOverweightmedicine.diseaseObesityEndocrinologyCross-Sectional StudiesSympathetic nervous systemInsulin Resistancebusiness
researchProduct

White blood cell counts as risk markers of developing metabolic syndrome and its components in the Predimed study.

2013

Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; TRIAL REGISTRATION Controlled-Trials.comISRCTN35739639. BACKGROUND The Metabolic Syndrome (MetS) is a cluster of metabolic abnormalities that includes hyperglucemia, hypertension, dyslipidemia and central obesity, conferring an increased risk of cardiovascular disease. The white blood cell (WBC) count has been proposed as a marker for predicting cardiovascular risk. However, few prospective studies have evaluated the relationship between WBC subtypes and risk of MetS. METHODS Participants were recruited from seven PREDIMED study centers. Both a baseline cross-sectional (n = 4,377) and a prospe…

MaleSíndrome metabòlicaMediterranean dietNeutrophilsEpidemiologyEstudios transversalesMetabolic disorders:Named Groups::Persons::Age Groups::Adult::Aged::Aged 80 and over [Medical Subject Headings]Disease:Named Groups::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings]Diet Mediterranean:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors [Medical Subject Headings]:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]Leukocyte CountLymphocitesRisk FactorsBlood plasmaPathologyMedicineProspective StudiesProspective cohort studyAged 80 and overMetabolic SyndromeClinical ChemistryMultidisciplinary:Analytical Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Nutrition Therapy::Diet Therapy::Diet Mediterranean [Medical Subject Headings]QRMiddle AgedMetabolic syndromeClinical Laboratory Sciences1932-6203:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cross-Sectional Studies [Medical Subject Headings]medicine.anatomical_structureCholesterolCardiovascular diseasesCardiovascular DiseasesMedicineWhite blood cellsFemalePublic HealthEnfermedades cardiovascularesResearch Articlemedicine.medical_specialty:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal Studies::Prospective Studies [Medical Subject Headings]Recuento de linfocitosScience:Check Tags::Male [Medical Subject Headings]Mediterranean cookingDiagnostic MedicineInternal medicineWhite blood cell:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Cytological Techniques::Cell Count::Blood Cell Count::Leukocyte Count::Lymphocyte Count [Medical Subject Headings]Cuina mediterràniaHumansLymphocyte CountObesity:Named Groups::Persons::Age Groups::Adult::Aged [Medical Subject Headings]:Diseases::Cardiovascular Diseases [Medical Subject Headings]Cardiovascular Disease EpidemiologyAged:Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Metabolic Syndrome X [Medical Subject Headings]business.industryMalalties cardiovascularsRecuento de leucocitosSíndrome X metabólicomedicine.diseaseObesityLong-Term CareDieta mediterránea:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Cytological Techniques::Cell Count::Blood Cell Count::Leukocyte Count [Medical Subject Headings]Biomarker EpidemiologyCross-Sectional Studies:Check Tags::Female [Medical Subject Headings]GeriatricsImmunologyClinical ImmunologyPreventive MedicineMetabolic syndrome:Anatomy::Cells::Blood Cells::Leukocytes::Granulocytes::Neutrophils [Medical Subject Headings]businessDyslipidemiaBiomarkersGeneral Pathology
researchProduct

Leisure-Time physical activity, sedentary behaviour and diet quality are associated with metabolic syndrome severity: the PREDIMED-Plus Study

2020

The authors especially thank the PREDIMED-Plus participants for their enthusiastic collaboration, the PREDIMED-Plus personnel for outstanding support, and the personnel of all associated primary care centres for their exceptional effort. CIBEROBN, CIBERESP and CIBERDEM are initiatives of Instituto de Salud Carlos III, Spain. We thank the PREDIMED-Plus Biobank Network, part of the National Biobank Platform of Instituto de Salud Carlos III for storing and managing biological samples.

MaleSíndrome metabòlicaMediterranean diethumanosejercicio físico030204 cardiovascular system & hematologyOverweightSeverity of Illness Indexlaw.inventionchemistry.chemical_compound0302 clinical medicineSedentarismeRandomized controlled triallaw030212 general & internal medicineDepression (differential diagnoses)mediana edad2. Zero hungerMetabolic SyndromeancianoNutrition and Dietetics4. EducationMiddle Aged16. Peace & justiceMetabolic syndrome3. Good healthFemalemedicine.symptomlcsh:Nutrition. Foods and food supplymedicine.medical_specialtylcsh:TX341-641Article03 medical and health sciencesFood PreferencesMediterranean cookingLeisure ActivitiesInternal medicineMediterranean dietCuina mediterràniamedicineingesta energéticaHumansíndice de gravedad de la enfermedadExerciseMetabolic syndrome severityAgedbusiness.industryCholesterolPhysical activityactividades de ocioSedentary behaviourAnthropometryPhysical fitnessmedicine.diseaseObesitypreferencias alimenticiasSedentary behaviorCross-Sectional StudieschemistryDepression riskMetabolic syndromeSedentary BehaviorbusinessEnergy IntakeFood Scienceestudios transversalesCondició física
researchProduct

Reduced circulating sTWEAK levels are associated with metabolic syndrome in elderly individuals at high cardiovascular risk

2014

BACKGROUND: The circulating soluble TNF-like weak inducer of apoptosis (sTWEAK) is a cytokine that modulates inflammatory and atherogenic reactions related to cardiometabolic risk. We investigated the association between sTWEAK levels and metabolic syndrome (MetS) and its components in older subjects at high cardiovascular risk. METHODS: Cross-sectional analysis of 452 non-diabetic individuals (men and women aged 55-80 years) at high cardiovascular risk. MetS was defined by AHA/NHLBI and IDF criteria. Logistic regression analyses were used to estimate odds ratios (ORs) for MetS and its components by tertiles of serum sTWEAK concentrations measured by ELISA. RESULTS: sTWEAK concentrations we…

MaleSíndrome metabòlicamedicine.medical_specialtyEpidemiologyRisk factors in diseasesCross-sectional studyEndocrinology Diabetes and MetabolismRenal functionInsulin resistanceRisk FactorsInternal medicineDiabetes mellitusmedicineHumansEpidemiologiasTWEAKAbdominal obesityOriginal InvestigationAgedAged 80 and overMetabolic SyndromeMalalties cardiovascularsFactors de risc en les malaltiesbusiness.industryBiochemical markersHypertriglyceridemiaCytokine TWEAKInsulin resistanceOdds ratioMiddle AgedCardiovascular riskmedicine.diseaseMetabolic syndromeCross-Sectional StudiesCardiovascular diseasesCardiovascular DiseasesTumor Necrosis FactorsMarcadors bioquímicsFemaleResistència a la insulinamedicine.symptomMetabolic syndromeCardiology and Cardiovascular MedicinebusinessBiomarkersCardiovascular Diabetology
researchProduct

Learning to Eat Vegetables in Early Life: The Role of Timing, Age and Individual Eating Traits

2014

Vegetable intake is generally low among children, who appear to be especially fussy during the pre-school years. Repeated exposure is known to enhance intake of a novel vegetable in early life but individual differences in response to familiarisation have emerged from recent studies. In order to understand the factors which predict different responses to repeated exposure, data from the same experiment conducted in three groups of children from three countries (n = 332) aged 4-38 m (18.9 +/- 9.9 m) were combined and modelled. During the intervention period each child was given between 5 and 10 exposures to a novel vegetable (artichoke puree) in one of three versions (basic, sweet or added e…

MaleTasteTime Factorsplate-clearerPhysiologyEpidemiology030309 nutrition & dieteticshabitude alimentaireNovel foodPediatrics0302 clinical medicineFeeding behaviorVegetablesMedicine and Health SciencesPsychologyMedicinePublic and Occupational HealthFood sciencetoddlersPediatric EpidemiologyEating behaviourenfant2. Zero hunger0303 health scienceslearningMultidisciplinaryinfantsQAge FactorsChild HealthRExperimental Psychologyacceptation de légumeapprentissageEarly lifePhysiological ParametersResearch DesignChild PreschoolAlimentation et NutritionMedicineFemaleBehavioral and Social Aspects of HealthResearch ArticleallaitementClinical Research DesignScienceconsommation alimentaire030209 endocrinology & metabolismResearch and Analysis MethodsfussinessFood Preferences03 medical and health scienceschildrenIntervention (counseling)vegetable intakecaractère alimentaire difficileFood and NutritionHumansObesityNutritionBehaviorbusiness.industryBody WeightCognitive PsychologyInfantBiology and Life ScienceslégumeFeeding Behaviorjeune enfantchildren;toddlers;infants;vegetable intake;learning;fussiness;age;eating traits;plate-clearer;non-eater;jeune enfant;nourrisson;acceptation de légume;apprentissage;caractère alimentaire difficilenon-eaternourrissonageExposure periodCognitive Scienceeating traitsbusiness[SDV.AEN]Life Sciences [q-bio]/Food and NutritionBreast feedingNeuroscienceDemographyPLoS ONE
researchProduct

Obesity causes PGC‐1α deficiency in the pancreas leading to marked IL‐6 upregulation via NF‐κB in acute pancreatitis

2019

Obesity is associated with local and systemic complications in acute pancreatitis. PPARγ coactivator 1α (PGC-1α) is a transcriptional coactivator and master regulator of mitochondrial biogenesis that exhibits dysregulation in obese subjects. Our aims were: (1) to study PGC-1α levels in pancreas from lean or obese rats and mice with acute pancreatitis; and (2) to determine the role of PGC-1α in the inflammatory response during acute pancreatitis elucidating the signaling pathways regulated by PGC-1α. Lean and obese Zucker rats and lean and obese C57BL6 mice were used first; subsequently, wild-type and PGC-1α knockout (KO) mice with cerulein-induced pancreatitis were used to assess the inflam…

MaleTaurocholic Acid0301 basic medicinemedicine.medical_specialtyPGC-1αPathology and Forensic Medicine03 medical and health sciencesDownregulation and upregulationInternal medicineAnimalsMedicineObesityPhosphorylationInterleukin 6PancreasCeruletideMice KnockoutIL-6biologyp65Interleukin-6business.industryNF-kappa BTranscription Factor RelAmedicine.diseasePeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaRats ZuckerUp-Regulation3. Good healthMice Inbred C57BLDisease Models Animal030104 developmental biologyEndocrinologymedicine.anatomical_structureMitochondrial biogenesisPancreatitisbiology.proteinPancreatitisAcute pancreatitisPPARGC1AbusinessPancreasCeruletideSignal TransductionThe Journal of Pathology
researchProduct